Chattahoochee Physicians Laboratory Services, LLC

Chattahoochee Physicians Laboratory Services, LLC was paid $811K by Medicaid between Mar 2018 and Jul 2023, across 75 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 62% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Georgia

Rank by total paid#26 of 66

Median peer was paid$178K

This provider vs. median4.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	754	$2K
2019	141	$6K
2020	1,224	$45K
2021	6,041	$298K
2022	7,519	$244K
2023	6,825	$214K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	62%	7,323	6,014	$500K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	22%	6,944	5,674	$182K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	6.6%	334	278	$53K
87481		1.2%	339	281	$10K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	1.2%	122	110	$9K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	1.1%	166	128	$9K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	<1%	537	361	$7K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	31	31	$5K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	114	103	$2K
87640		<1%	339	281	$2K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	114	103	$2K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	178	123	$2K

63 more codes

87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	365	$2K
87653		<1%	340	$2K
87500		<1%	223	$2K
82670		<1%	155	$1K
84403		<1%	171	$1K
84402		<1%	154	$1K
84270		<1%	173	$1K
83002		<1%	147	$1K
83001		<1%	155	$1K
84443	Thyroid stimulating hormone (TSH)	<1%	179	$980.02
84481		<1%	173	$969.23
83036	Hemoglobin; glycosylated (A1C)	<1%	179	$922.52
82533		<1%	172	$919.63
82607		<1%	185	$915.20
84154		<1%	94	$892.35
82746		<1%	177	$876.93
82728		<1%	172	$788.06
86376		<1%	147	$785.23
87150		<1%	187	$783.28
APT17		<1%	52	$691.08
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	160	$641.20
84153		<1%	97	$591.66
84144		<1%	146	$590.98
84439		<1%	174	$525.93
84146		<1%	64	$435.78
80061	Lipid panel	<1%	177	$365.66
83735		<1%	155	$352.87
80053	Comprehensive metabolic panel	<1%	175	$278.49
84702		<1%	54	$228.40
84703		<1%	54	$139.57
83970		<1%	18	$116.96
84550		<1%	171	$112.82
83880		<1%	14	$96.18
83003		<1%	19	$55.06
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	36	$50.94
83525		<1%	17	$46.90
86141		<1%	20	$42.76
83874		<1%	19	$42.66
82172		<1%	20	$36.64
82553		<1%	18	$32.71
84100		<1%	21	$30.30
83540		<1%	21	$30.30
84466		<1%	18	$30.18
84484		<1%	14	$27.90
83550		<1%	18	$25.00
82977		<1%	17	$23.80
83690		<1%	18	$22.74
82550		<1%	20	$21.50
82150		<1%	18	$21.40
83615		<1%	18	$19.94
82248		<1%	17	$16.58
86431		<1%	18	$16.08
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	247	$15.88
83090		<1%	18	$15.82
83721		<1%	19	$8.94
84436		<1%	16	$3.23
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	0%	32	$0.00
87541		0%	32	$0.00
84480		0%	45	$0.00
87581		0%	32	$0.00
87561		0%	32	$0.00
87486		0%	32	$0.00
87555		0%	32	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBAUER, DANIELLE (LAB ADMINISTRATOR)

Same official

Other billing entities under BAUER, DANIELLE

Full network →

Provider	Location	Paid
Stone Clinical Laboratories LLC	New Orleans, LA	$3.26M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.